Physicians' Academy for Cardiovascular Education

Differential associations seen between Lp(a) levels and stroke, depending on AF-status

Jan. 9, 2018 - Aronis KN et al., - J Am Heart Assoc. 2017

In a prospective community-based cohort, Lp(a) ≥50 mg/dL was associated with higher stroke risk in those without AF, but not in those with AF, nor with an elevated risk of AF.

New onset and paroxysmal AF increase the risk of adverse outcomes in HF

Dec. 6, 2017 - Mogensen UM et al. - J Am Coll Cardiol. 2017

In heart failure patients with a reduced EF, paroxysmal AF and new onset AF were associated with a greater risk of adverse outcomes, including HF hospitalization and stroke, but not mortality.

First FDA clearance for medical device accessory for smartwatch

Dec. 4, 2017 - news

KardiaBand evaluates heart rate and physical activity, and instantly pushes notifications to take an EKG, which can be recorded in 30 second with its integrated sensor.

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

AHA 2017 - Anaheim, CA, USA

Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.
The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.

AHA 2017 The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.

Epicardial botulinum toxin injection for now does not lower burden of postoperative AF

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Nathan Waldron (Duke University Medical Center, Durham, NC, USA

Nov. 20, 2017 - news

AHA 2017 Neurotoxin injection yielded numerically lower risk of POAF in TNT-POAF study, along with a shorter duration of first POAF episode, but the study may have been underpowered.

AF patients receiving oral anticoagulation have a lower risk of dementia

Nov. 8, 2017 - Friberg L & Rosenqvist M - Eur Heart J 2017

In a large retrospective cohort study, the risk of dementia was higher without oral anticoagulant treatment in patients with AF, compared with AF patients receiving oral anticoagulation.

Long term cardiac monitoring with implanted device frequently reveals previously undiagnosed AF

Nov. 2, 2017 - Reiffel JA - JAMA Cardiology 2017

An analysis of the REVEAL AF study, demonstrated a substantial incidence of previously undiagnosed AF when insertable cardiac monitors were used for 18 to 30 months in patients at high risk for AF and stroke.

High risk of ischemic and hemorrhagic events in AF patients with OAC contraindication

Oct. 25, 2017 - Redfors B, et al. - JACC Clinical Electrophysiology 2017

AF patients not taking OAC due to a previous bleeding event have a considerably higher risk of ischemic and hemorrhagic events and death, particularly with a history of intracranial hemorrhage.

NT-proBNP levels predict outcomes in HF patients with or without atrial fibrillation

Oct. 19, 2017 - Kristensen SL et al. - Circ Heart Fail. 2017

a concentration of 400 pg/mL, any given concentration of NT-proBNP had a similar predictive value for adverse outcomes in HFrEF patients with and without AF.

SBP variability is associated with clinical outcomes in atrial fibrillation patients

Oct. 17, 2017 - Proietti M, et al. - Hypertension 2017

In the AFFIRM study, SBP variability was inversely associated with the quality of anticoagulation control in AF patients, and increasing SBP variability was associated with a higher risk of major adverse clinical outcomes.

International joint consensus document on hypertension and cardiac arrhythmias

Sep. 20, 2017 - news

Considering the close relationship between hypertension and arrhythmias, the EHRA and ESC council on hypertension teamed up with other international societies to compose management recommendations.

NOAC-based dual therapy is safer than triple therapy for stent placement in AF patients

ESC 2017 - Barcelona

Aug. 31, 2017 - news

ESC 2017 Fewer major bleedings with dual therapy of dabigatran and platelet inhibitor than with triple therapy with warfarin, platelet inhibitor and aspirin, in AF patients receiving a stent in RE-DUAL PCI..